Recent insider buying activity includes John Paulson's $14.7 million purchase of 2,788,608 Bausch Health Companies (BHC) shares at $5.27 each, with the stock price subsequently increasing by approximately 11.0% based on Friday's trading high; Paulson's purchase is his first insider buy in the past year. Additionally, Meritage Homes (MTH) Director Joseph Keough bought 4,000 shares at $66.16 each for a total of $264,640, while the stock is currently trading down 0.7% on Friday and investors can purchase shares cheaper than Keough's purchase price.
Recent insider trading activity signals potential undervaluation in specific equities, a key interest for bargain-hunting investors. John Paulson's substantial $14.70 million acquisition of 2,788,608 shares in Bausch Health Companies (BHC) at $5.27 per share is particularly noteworthy. This investment has already demonstrated a swift paper gain for Paulson, with the shares appreciating approximately 11.0% to a trading high of $5.85, while BHC's stock overall rose about 4.3% on Friday. This marks Paulson's first insider purchase in BHC over the past year, lending more credence to the bullish signal, which aligns with BHC's individual sentiment score of 0.75. Concurrently, Meritage Homes (MTH) experienced insider buying from Director Joseph Keough, who purchased 4,000 shares for $264,640 at $66.16 each. This is Keough's second purchase in the last twelve months. In contrast to BHC, MTH's stock traded down approximately 0.7% on Friday, with its price falling to as low as $65.00, offering a 1.8% discount compared to Keough's purchase price. The sentiment for MTH is more subdued at 0.3, despite the insider activity. The broader market interpretation of these events leans moderately positive, reflecting a generally bullish tone on these specific insider actions.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment
